MCAZ clarifies nifedipine recall affects specific batches

The Medicines Control Authority of Zimbabwe (MCAZ) has clarified that its recall of Nifedipine only affects specific Nifelat 10mg batches, not all versions, following public confusion. The clarification was reported by iHarare, emphasizing that the action is targeted to ensure safety while minimizing disruption to essential treatments. MCAZ's statement aims to address public concerns and provide clear guidance on the affected products. The recall is part of a routine quality control measure, and MCAZ assures that other batches are safe for use. Patients are advised to check their medication's batch number and consult healthcare providers if they have any concerns. This clarification is crucial to prevent unnecessary panic and ensure continued access to essential medication for hypertension and angina.